New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 20, Issue 4, Pages 425-429
Publisher
Springer Nature
Online
2014-03-24
DOI
10.1038/nm.3489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
- (2013) Daniela Boehm et al. CELL CYCLE
- Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV Transcription
- (2013) Koen Bartholomeeusen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel PCR Assay for Quantification of HIV-1 RNA
- (2013) L. Shan et al. JOURNAL OF VIROLOGY
- Reactivation of latent HIV by histone deacetylase inhibitors
- (2013) Kotaro Shirakawa et al. TRENDS IN MICROBIOLOGY
- Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
- (2013) Thomas Rasmussen et al. Human Vaccines & Immunotherapeutics
- Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
- (2013) Gregory M. Laird et al. PLoS Pathogens
- Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog
- (2012) Geneviève Doyon et al. AIDS
- Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral Therapy
- (2012) J. Blazkova et al. JOURNAL OF INFECTIOUS DISEASES
- BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
- (2012) Camellia Banerjee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
- (2012) Brian A. DeChristopher et al. Nature Chemistry
- The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
- (2012) Zichong Li et al. NUCLEIC ACIDS RESEARCH
- Reactivation of Latent HIV-1 by Inhibition of BRD4
- (2012) Jian Zhu et al. Cell Reports
- Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
- (2011) Shailesh K. Choudhary et al. Annual Review of Pharmacology and Toxicology
- Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
- (2011) S. Xing et al. JOURNAL OF VIROLOGY
- Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
- (2010) Rajeev Mehla et al. PLoS One
- The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
- (2010) Jonathan Karn Current Opinion in HIV and AIDS
- Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
- (2009) Nancie M. Archin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
- (2009) Xavier Contreras et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Challenge of Finding a Cure for HIV Infection
- (2009) D. D. Richman et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now